report their CRF as severe. [5] [6] [7] 22 CRF is a chronic problem in over two-thirds of cancer survivors, and nearly 40 % describe it as severe for at least six months following treatment. [5] [6] [7] 22 CRF is more common, more severe, and persistent in patients who receive more than one type of treatment. [5] [6] [7] 22 CRF is a dose-limiting toxicity resulting from established therapies and from newer targeted agents (such as tyrosine kinase inhibitors), ultimately limiting their effective use alone and in combination with other agents. 24 CRF is associated with a variety of co-morbidities, such as sleep problems, depression, pain, medication side effects, nutritional imbalance, and physical inactivity. [5] [6] [7] 22 CRF is often described by patients as the most distressing side effect of treatment, even more so than nausea, vomiting, sleep problems, pain, and depression, due to its impact on their ability to perform activities of daily living and QOL. [5] [6] [7] 22 Cognitive Problems
Cognitive impairments (e.g., problems with memory, attention, and executive function), for which there is no treatment, are a clinically significant problem for up to 75 % of breast cancer patients during chemotherapy and persist in 20-35 % of survivors during the years following treatment. [25] [26] [27] [28] [29] [30] [31] [32] Patients receiving chemotherapy have much greater difficulty with cognitive function than patients receiving radiation treatments. 33 These cognitive problems can have a severe negative effect on the mental and physical well-being of patients and impair function (e.g., activities of daily living) and QOL. For example, one study found that 57 % of women with breast cancer were unable to do their jobs as effectively, unable to maintain the same job, or unable to work at all following chemotherapy due to difficulty with memory, maintaining attention, and accomplishing tasks requiring executive function. 29, 34 Sleep Problems, Depression, Pain, and Anxiety
Between 30 and 50 % of cancer patients report sleep disruption. 35, 36 Poor sleep quality is common among cancer patients and survivors;
it is several times more prevalent than in the general population. 35, 36 Patients and survivors who spend a significant amount of time napping report increased sleep problems. 37 Additionally, 10-25 % of cancer patients report depression. 38 Pain is also common; 45-59 % of cancer patients and survivors report pain. 39 Anxiety is reported by approximately half of cancer patients and survivors; 20 % meet the clinical criteria for an anxiety disorder. 40 
Physical Dysfunction
Cancer and its treatments can lead to impaired muscle function through atrophy and loss of strength. 41, 42 Reduced muscle mass and strength impair a cancer patient's ability to perform activities of daily living and remain independent during and following treatment, which is of particular concern among older patients. 43, 44 Chemotherapy and radiation treatments may also lead to cardiac and pulmonary dysfunction. 4, 5, 45 Patients treated with anthracyclines, taxanes and/or trastuzumab may develop acute or chronic cardiac dysfunction and, in some cases, the maximum cumulative dose for these agents is limited due to potential cardiomyopathy. 46, 47, 49 Cardiotoxicities can develop during treatment or become manifest years after treatment completion. 48 Radiation to the chest increases the risk of cardiac damage. 49 Patients treated with methotrexate and bleomycin may develop pulmonary toxicities. [50] [51] [52] [53] Patients treated with chemotherapy, oophorectomy, and aromatase inhibitors often decrease production of endogenous estrogens and develop premature menopause leading to reduced bone mineral density and an increased risk of fracture. 
Resistance Exercise During and Following Treatment
Resistance exercise involves muscle contraction against resistance and leads to improvements in muscular function and bone density. 106 Resistance can be achieved by using hand-held dumbbells, resistance bands, or even body weight. 106 Resistance training is safe, reduces side effects, and improves QOL when performed during and following cancer treatment. 69, 89, 90, 92, 110 During chemotherapy for breast cancer, resistance training, consisting of two sets of eight to 12 repetitions, three times per week for the duration of chemotherapy, resulted in an increase in upper and lower body strength and lean body mass when compared to a usual care control group. 67 Courneya and colleagues also found that breast cancer patients undergoing chemotherapy were able to tolerate higher relative doses of chemotherapy if engaging in resistance exercise. 67 Resistance training is safe and efficacious for breast cancer survivors who have recently completed primary treatment. Schmitz and colleagues implemented a twice weekly resistance training intervention lasting six to 12 months. The intervention was safe and resulted in decreased body fat and increased lean body mass. 89 Ahmed and colleagues also assessed Associations between interleukin-6 levels and sleep efficiency and duration suggested that improvements in sleep due to exercise may be mediated by cytokines. 96 In addition, participants were able to progressively increase the number of steps walked per day from 5,000 to nearly 12,000 despite undergoing radiation treatments. 120 Joseph and colleagues reported improvements in sleep, QOL, treatment tolerance, and mood, among patients participating in yoga while receiving radiation treatments. 121 The intervention consisted of a 90-minute session, 
Providing Information
The majority of cancer patients report that they do not discuss initiating or continuing an exercise program with their treating oncologist or primary care physician throughout their cancer experience. 6 ,123 Yet, research
shows that cancer patients want their oncologists to initiate discussions about exercise. 124 Cancer patients would prefer to receive information on exercise during the time period in which they are receiving treatments (i.e., during chemotherapy and during radiation therapy); specifically, they prefer receiving this information shortly after they have initiated treatments and prior to completion. 125 Given the benefits of exercise during cancer treatments, oncologists should routinely discuss exercise and physical activity with their patients. The information below, in Figure 1 , and in Tables 1 and 2 can help guide these discussions.
Considerations and Contraindications for Exercise
Oncologists should discuss with cancer patients and survivors how they can safely begin or continue an exercise program during and after treatments. Patients must also be informed of any potential contraindications (e.g., orthopedic, cardiopulmonary, oncologic) that might affect their exercise safety and tolerance. 90 Contraindications do not necessarily mean that a cancer patient or survivor cannot exercise at all; in fact, this is rarely the case. In most instances, contraindications simply require specific modifications to the exercise regimen so that the individual can exercise safely and still achieve physical and mental health benefits (see Table 1 ). Many cancer patients will be able to safely initiate or continue an exercise program with the goal of achieving the levels of exercise, both aerobic and resistance, recommended by the American College of Sports Medicine (ACSM) for cancer patients and survivors. 90 Active exercisers or those at low to moderate risk, based on the ACSM guidelines, are not required to obtain medical clearance to continue or begin a low to moderate exercise program (see Figure 1) . 90 However, a medical assessment by qualified medical professionals (e.g., oncologist, surgeon, cardiologist, orthopedist, physical therapist) along with appropriate management of cancer-specific, cardiovascular, pulmonary, metabolic, orthopedic or other co-morbid conditions, is advisable for individuals at moderate risk wishing to participate in vigorous exercise and those at high risk initiating low to moderate intensity exercise, based on the ACSM guidelines. 90 Cancer survivors should be evaluated for musculoskeletal morbidities, peripheral neuropathies, and fractures, if they have received or are currently on hormonal treatments. 90 Cancer patients with additional concerns, such as bone metastasis and cardiac toxicity, should be assessed to determine if and how they can safely exercise. 90 Medical evaluations should be conducted prior to the initiation of exercise testing, prescription and participation. It is strongly suggested that exercise testing, prescription and monitoring be done by qualified exercise professionals, as described in the next section, for all cancer patients and survivors, but, particularly, for individuals at moderate risk beginning or continuing vigorous exercise and those at high risk commencing or continuing any level of exercise. 90 In all cases, the exercise prescription should be developed to target relevant cancer-and general-health-related outcomes. 90 
Exercise Professionals
Exercise participation and adherence during and following cancer treatments are increased if physicians are involved in making recommendations and referring patients. 126 Referral to a qualified exercise specialist is preferred. 90 Minimum qualifications include a bachelor's degree or higher in an accredited exercise science or kinesiology program. Certification as a Cancer Exercise Trainer from the American College of Sports Medicine (ACSM) further ensures that the exercise professional has the minimum competencies required to safely and effectively prescribe exercise for cancer patients and survivors. 90 This certification, which can be obtained by individuals with varied educational backgrounds (e.g., exercise physiologists, physical therapists, nurses), requires training in the unique cancer-specific issues that need to be addressed when a patient or survivor plans to start or continue exercise throughout primary treatment and into long-term survivorship.
The certification also provides a very useful professional competency benchmark for oncology professionals who are looking for exercise referral options in their local communities.
90,106,127

Exercise Prescription Guidelines
Since cancer survivors are a heterogeneous group, their exercise prescription should be individualized and tailored based on health status, disease trajectory, previous and/or current treatment, current fitness level and past and present exercise participation and preferences in order to be safe and effective. 90, 128, 130 Introducing a low to moderate intensity exercise intervention and slowly increasing its frequency, intensity and duration over a period of weeks is recommended. 90, 106, 130 In 2010, the Exercise Recommendations for Cancer-Related Side Effects-A Review Table 2 ). 90 The guidelines also suggest that individuals with conditions that limit their ability to perform exercise should participate in physical activity to the fullest extent they are able, even if they are unable to achieve the recommended levels. 90, 129, 130 Results from clinical trials that focus on the use of exercise for improving cancer-related outcomes are also helpful to health professionals when testing, prescribing, and monitoring exercise behavior and results. [115] [116] [117] [118] [119] [120] Low intensity exercise is also safe and well-tolerated by cancer patients with metastatic disease. [133] [134] [135] [136] [137] [138] Lymphedema risk can be reduced by use of compression sleeves when appropriate, although recent research suggests that resistance training does not result in increased incidence of lymphedema. 90 Generally, it is prudent to advise cancer patients and survivors to avoid excessive high-intensity exercise, which can compromise the immune system and interfere with treatment and recovery. 
